GSTM, GSTT and p53 polymorphisms as modifiers of clinical outcome in colorectal cancer.

András Csejtei, Antal Tibold, Zsuzsa Varga, Katalin Koltai, Ágoston Ember, Zsuzsa Orsós, Gergely Fehér, Örs Péter Horváth, István Ember, István Kiss

PubMed · 2008 · 43 citations · 17 references

Abstract

The significance of the investigated polymorphisms in prognosis is dependent on the tumor stage. These parameters might be used in certain cases as prognostic biomarkers in clinical diagnostics and in the planning of individual therapy.

References

17